Ken Griffin Xencor Inc Transaction History
Citadel Advisors LLC
- $550 Billion
- Q2 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Xencor Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 220,268 shares of XNCR stock, worth $1.71 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
220,268
Previous 3,400
6378.47%
Holding current value
$1.71 Million
Previous $36,000
4708.33%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding XNCR
# of Institutions
203Shares Held
81.7MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY11.1MShares$86 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA10.5MShares$81.6 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.62MShares$66.8 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.14MShares$47.6 Million4.16% of portfolio
-
State Street Corp Boston, MA3.82MShares$29.6 Million0.0% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $463M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...